Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Erectile Dysfunction Treatment Drugs Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Erectile Dysfunction Treatment Drugs Market Status and Forecast (2016-2027)
      • 1.3.2 Global Erectile Dysfunction Treatment Drugs Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Erectile Dysfunction Treatment Drugs Supply by Company

    • 2.1 Global Erectile Dysfunction Treatment Drugs Sales Volume by Company
    • 2.2 Global Erectile Dysfunction Treatment Drugs Sales Value by Company
    • 2.3 Global Erectile Dysfunction Treatment Drugs Price by Company
    • 2.4 Erectile Dysfunction Treatment Drugs Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Erectile Dysfunction Treatment Drugs Market Status by Category

    • 3.1 Erectile Dysfunction Treatment Drugs Category Introduction
      • 3.1.1 Phosphodiesterase Type 5 Inhibitors
      • 3.1.2 Prostaglandin E1
    • 3.2 Global Erectile Dysfunction Treatment Drugs Market by Category
      • 3.2.1 Global Erectile Dysfunction Treatment Drugs Sales Volume by Category (2016-2021)
      • 3.2.2 Global Erectile Dysfunction Treatment Drugs Sales Value by Category (2016-2021)
      • 3.2.3 Global Erectile Dysfunction Treatment Drugs Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Erectile Dysfunction Treatment Drugs Market Status by End User/Segment

    • 4.1 Erectile Dysfunction Treatment Drugs Segment by End User/Segment
      • 4.1.1 Hospitals
      • 4.1.2 Clinic
      • 4.1.3 Others
    • 4.2 Global Erectile Dysfunction Treatment Drugs Market by End User/Segment
      • 4.2.1 Global Erectile Dysfunction Treatment Drugs Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Erectile Dysfunction Treatment Drugs Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Erectile Dysfunction Treatment Drugs Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Erectile Dysfunction Treatment Drugs Market Status by Region

    • 5.1 Global Erectile Dysfunction Treatment Drugs Market by Region
      • 5.1.1 Global Erectile Dysfunction Treatment Drugs Sales Volume by Region
      • 5.1.2 Global Erectile Dysfunction Treatment Drugs Sales Value by Region
    • 5.2 North America Erectile Dysfunction Treatment Drugs Market Status
    • 5.3 Europe Erectile Dysfunction Treatment Drugs Market Status
    • 5.4 Asia Pacific Erectile Dysfunction Treatment Drugs Market Status
    • 5.5 Central & South America Erectile Dysfunction Treatment Drugs Market Status
    • 5.6 Middle East & Africa Erectile Dysfunction Treatment Drugs Market Status

    6 North America Erectile Dysfunction Treatment Drugs Market Status

    • 6.1 North America Erectile Dysfunction Treatment Drugs Market by Country
      • 6.1.1 North America Erectile Dysfunction Treatment Drugs Sales Volume by Country (2016-2021)
      • 6.1.2 North America Erectile Dysfunction Treatment Drugs Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Erectile Dysfunction Treatment Drugs Market Status

    • 7.1 Europe Erectile Dysfunction Treatment Drugs Market by Country
      • 7.1.1 Europe Erectile Dysfunction Treatment Drugs Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Erectile Dysfunction Treatment Drugs Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Erectile Dysfunction Treatment Drugs Market Status

    • 8.1 Asia Pacific Erectile Dysfunction Treatment Drugs Market by Country
      • 8.1.1 Asia Pacific Erectile Dysfunction Treatment Drugs Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Erectile Dysfunction Treatment Drugs Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Erectile Dysfunction Treatment Drugs Market Status

    • 9.1 Central & South America Erectile Dysfunction Treatment Drugs Market by Country
      • 9.1.1 Central & South America Erectile Dysfunction Treatment Drugs Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Erectile Dysfunction Treatment Drugs Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Erectile Dysfunction Treatment Drugs Market Status

    • 10.1 Middle East & Africa Erectile Dysfunction Treatment Drugs Market by Country
      • 10.1.1 Middle East & Africa Erectile Dysfunction Treatment Drugs Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Erectile Dysfunction Treatment Drugs Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Erectile Dysfunction Treatment Drugs Manufacturing Cost Analysis
    • 11.5 Erectile Dysfunction Treatment Drugs Sales Channel and Distributors Analysis
      • 11.5.1 Erectile Dysfunction Treatment Drugs Sales Channel
      • 11.5.2 Erectile Dysfunction Treatment Drugs Distributors
    • 11.6 Erectile Dysfunction Treatment Drugs Downstream Major Buyers

    12 Global Erectile Dysfunction Treatment Drugs Market Forecast by Category and by End User/Segment

    • 12.1 Global Erectile Dysfunction Treatment Drugs Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Erectile Dysfunction Treatment Drugs Forecast by Category
      • 12.2.1 Global Erectile Dysfunction Treatment Drugs Sales Volume Forecast by Category
      • 12.2.2 Global Erectile Dysfunction Treatment Drugs Sales Value Forecast by Category
      • 12.2.3 Global Erectile Dysfunction Treatment Drugs Price Forecast by Category
    • 12.3 Global Erectile Dysfunction Treatment Drugs Forecast by End User/Segment
      • 12.3.1 Global Erectile Dysfunction Treatment Drugs Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Erectile Dysfunction Treatment Drugs Sales Value Forecast by End User/Segment
      • 12.3.3 Global Erectile Dysfunction Treatment Drugs Price Forecast by End User/Segment

    13 Global Erectile Dysfunction Treatment Drugs Market Forecast by Region/Country

    • 13.1 Global Erectile Dysfunction Treatment Drugs Market Forecast by Region (2022-2027)
      • 13.1.1 Global Erectile Dysfunction Treatment Drugs Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Erectile Dysfunction Treatment Drugs Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Vivus, Inc.
      • 14.1.1 Company Information
      • 14.1.2 Erectile Dysfunction Treatment Drugs Product Introduction
      • 14.1.3 Vivus, Inc. Erectile Dysfunction Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Pfizer Inc.
      • 14.2.1 Company Information
      • 14.2.2 Erectile Dysfunction Treatment Drugs Product Introduction
      • 14.2.3 Pfizer Inc. Erectile Dysfunction Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Meda Pharmaceuticals
      • 14.3.1 Company Information
      • 14.3.2 Erectile Dysfunction Treatment Drugs Product Introduction
      • 14.3.3 Meda Pharmaceuticals Erectile Dysfunction Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Johnson & Johnson Services
      • 14.4.1 Company Information
      • 14.4.2 Erectile Dysfunction Treatment Drugs Product Introduction
      • 14.4.3 Johnson & Johnson Services Erectile Dysfunction Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Eli Lilly
      • 14.5.1 Company Information
      • 14.5.2 Erectile Dysfunction Treatment Drugs Product Introduction
      • 14.5.3 Eli Lilly Erectile Dysfunction Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Dong-A Pharmaceutical Co. Ltd
      • 14.6.1 Company Information
      • 14.6.2 Erectile Dysfunction Treatment Drugs Product Introduction
      • 14.6.3 Dong-A Pharmaceutical Co. Ltd Erectile Dysfunction Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Bayer AG
      • 14.7.1 Company Information
      • 14.7.2 Erectile Dysfunction Treatment Drugs Product Introduction
      • 14.7.3 Bayer AG Erectile Dysfunction Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Apricus Biosciences
      • 14.8.1 Company Information
      • 14.8.2 Erectile Dysfunction Treatment Drugs Product Introduction
      • 14.8.3 Apricus Biosciences Erectile Dysfunction Treatment Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Erectile Dysfunction Treatment Drugs market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Erectile Dysfunction Treatment Drugs market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Phosphodiesterase Type 5 Inhibitors
      Prostaglandin E1

      Segmented by End User/Segment
      Hospitals
      Clinic
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Vivus, Inc.
      Pfizer Inc.
      Meda Pharmaceuticals
      Johnson & Johnson Services
      Eli Lilly
      Dong-A Pharmaceutical Co. Ltd
      Bayer AG
      Apricus Biosciences
      Buy now